WASHINGTON—The U.S. Department of Human Services Office of the Inspector General (OIG) released a review of Medicare Part B payment trends for wound care products known as skin substitutes that the office said “raises major concerns about fraud, waste and abuse.”
In March 2023, OIG issued a report that identified significant gaps in manufacturer compliance with new average sales price (ASP) reporting requirements for skin substitutes.